Miskin
Anthony Miskin, West Yorkshire GB
Patent application number | Description | Published |
---|---|---|
20110251243 | Method and Kit for Assessing a Patient's Genetic Information, Lifestyle and Environment Conditions, and Providing a Tailored Therapeutic Regime - A method of determining a personalised therapeutic regime, comprising: receiving genetic information relating to a patient; determining genetic criteria relevant to a personalised therapeutic regime for the patient using the genetic information; receiving personal information relating to the patient; determining personal criteria relevant to the personalised therapeutic regime using the personal information; and combining the genetic criteria and the personal criteria to determine the personalised therapeutic regime for the patient. | 10-13-2011 |
James Miskin, Oxford GB
Patent application number | Description | Published |
---|---|---|
20090111106 | Vector System - The present invention provides a vector system comprising a mutated post-transcriptional regulatory element. In particular, the present invention relates to a mutated WPRE sequence that can efficiently express nucleotides of interest in a retroviral vector system. The present invention also relates to methods of delivering and expressing nucleotides of interest to a target cell. | 04-30-2009 |
20090325284 | VIRUS PURIFICATION - A process for producing a retroviral or lentiviral vector formulation comprising a filter-sterilisation step wherein the filter-sterilisation step is not the final step in the purification process. | 12-31-2009 |
James Miskin, The Oxford Science Park GB
Patent application number | Description | Published |
---|---|---|
20090017543 | Viral Vectors - The present invention relates to an integration defective retroviral vector particle for gene therapy comprising a viral genome, wherein said vector particle is capable of infecting a mammalian target cell. | 01-15-2009 |
20090075370 | Vectors - The present invention relates to a polynucleotide comprising a nucleotide sequence encoding a retroviral gag protein, wherein the gag protein comprises a heterologous RNA binding domain capable of recognising a corresponding sequence in an RNA genome to facilitate packaging of the RNA genome into a retroviral vector particle. | 03-19-2009 |